Medicines and Healthcare products Regulatory Agency

What's new

• 02 Jul 2009

  MHRA statement relating to recent class 2 drug recalls

  A number of medicine licence holders are carrying out precautionary medicine recalls at wholesale and pharmacy level following evidence that the medicines, all manufactured at MJ Biopharm in India, did not meet European standards of Good Manufacturing Practice (GMP).

• 01 Jul 2009

  Class 2 Drug Alert (Action within 48 hours): Strandhaven Limited - Amlodipine 5mg and 10mg Tablets - EL (09)A/21

  Strandhaven Limited is recalling batches of Amlodipine 5mg and 10mg Tablets due to serious Good Manufacturing Practice (GMP) deficiencies found during an inspection of their contract manufacturer.

• 01 Jul 2009

  Class 2 Drug Alert (Action within 48 hours) : Sandoz Limited - Multiple Product Drug Alert - Baclofen 10mg Tablets; Fluoxetine 20mg Capsules and Metformin 500mg and 850mg Tablets - EL (09)A/20

  Sandoz Limited is recalling the above products due to serious Good Manufacturing Practice (GMP) deficiencies found during an inspection of one of their contract manufacturers.

• 01 Jul 2009

  Class 2 Drug Alert (Action within 48 hours): LPC Medical (UK) Limited - Multiple Product Drug Alert - Co-Amilozide 5/50 Tablets; Metformin 500mg and 850mg Tablets; Naproxen 250mg and 500mg Tablets - EL (09)A/19

  LPC Medical (UK) Limited is recalling all unexpired stock of the above products due to serious Good Manufacturing Practice (GMP) deficiencies found during an inspection of their contract manufacturer.

• 01 Jul 2009

  Class 2 Drug Alert (Action within 48 hours): Karib Kemi Pharm Limited - Multiple Product Drug Alert - Doxazosin 2mg and 4mg Tablets; Fluoxetine 20mg Capsules - EL (09)A/18

  Karib Kemi Pharm Limited is recalling batches of the above products due to serious Good Manufacturing Practice (GMP) deficiencies found during an inspection of their contract manufacturer.

• 01 Jul 2009

  Class 2 Drug Alert (Action within 48 Hours): Milpharm Limited - Fluoxetine 20mg Capsules - EL (09)A/17

  Milpharm Limited is recalling all unexpired stock of Fluoxetine 20mg Capsules due to serious Good Manufacturing Practice (GMP) deficiencies found during an inspection of their contract manufacturer.

• 01 Jul 2009

  Information sent to healthcare professionals in June 2009 about the safety of medicines

  A list of letters sent to healthcare professionals in June 2009, to inform of new safety information and advice.
  

• 29 Jun 2009

  Good Clinical Practice (GCP) Non-Commercial Symposium: The Bigger Picture

  This hugely popular one-day seminar is aimed at those involved in the management and oversight of trials and GCP inspections, in a non-commercial capacity.

• 29 Jun 2009

  Class 2 Drug Alert (Action within 48 hours): Greystone Ltd - Amlodipine 5mg and 10mg Tablets - EL (09)A/16

  Greystone Ltd is recalling batches of Amlodipine 5mg and 10mg Tablets due to serious Good Manufacturing Practice (GMP) deficiencies found during an inspection of their contract manufacturer.

• 29 Jun 2009

  Class 2 Drug Alert (Action within 48 hours): Jubilant Pharmaceuticals NV and Wockhardt UK Ltd - Amlodipine 5mg and 10mg Tablets - EL (09)A/15

  Jubilant Pharmaceuticals NV is recalling Amlodipine 5mg and 10mg Tablets due to serious Good Manufacturing Practice (GMP) deficiencies found during an inspection of their contract manufacturer.